Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Plague Vaccine rF1V

rF1V · DynPort Vaccine Company LLC, A GDIT Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Plague Vaccine rF1V, covering 2011-12-02 to 2011-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers [Phase 2]

See pricing